Study guide

2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS

Key Takeaways Explain This Topic AI

Major burn injury triggers a profound systemic cytokine storm (TNF-α, IL-1β, IL-6, IL-8) and complement cascade activation (C3a, C5a) that damages distant, uninjured organs.

Endothelial glycocalyx shedding transforms the vascular tree into a pro-adhesive, hyperpermeable state, driving systemic capillary leak syndrome.

Standard SIRS criteria (fever, tachycardia, tachypnea, leukocytosis) have near-zero diagnostic specificity in major burns due to the obligatory baseline hypermetabolic state.

Multiple Organ Dysfunction Syndrome (MODS) results from a combination of persistent microvascular hypoperfusion, microthrombi, and cytokine cytotoxicity across pulmonary, renal, hepatic, and gastrointestinal systems.

Splanchnic vasoconstriction causes gut mucosal ischemia and epithelial tight junction breakdown, enabling bacterial and endotoxin translocation into mesenteric lymphatics.

Last updated: August 2026

2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS

Core Principle: In extensive burns (≥20% TBSA), the local wound is not merely an isolated anatomical injury; it serves as an unceasing engine of systemic inflammation . Circulating Damage-Associated Molecular Patterns (DAMPs), pro-inflammatory cytokines, and activated complement fragments provoke a whole-body inflammatory response known as Systemic Inflammatory Response Syndrome (SIRS) , which can rapidly spiral into Multiple Organ Dysfunction Syndrome (MODS) —the leading non-neurological cause of late burn mortality.

1. The Cascade of Systemic Inflammation: The Burn Cytokine Storm

Thermal destruction of cellular architecture releases intracellular components into the systemic circulation. These endogenous molecules function as Damage-Associated Molecular Patterns (DAMPs) (or alarmins), including:

  • High Mobility Group Box 1 ( HMGB1 )
  • Mitochondrial DNA ( mtDNA )
  • Heat shock proteins ( HSPs )
  • Extracellular ATP and nuclear histones ┌─────────────────────────────────────────────────────────────┐
  • │ Cellular Necrosis & Burn Wound Biomass │
  • │ Releases DAMPs (HMGB1, mtDNA, Heat Shock Proteins) │
  • └──────────────────────────────┬──────────────────────────────┘
  • │
  • ▼
  • ┌─────────────────────────────────────────────────────────────┐
  • │ Toll-Like Receptors (TLR-2, TLR-4, TLR-9) on │
  • │ Monocytes, Macrophages & Dendritic Cells │
  • └──────────────────────────────┬──────────────────────────────┘
  • │
  • ┌──────────────────────┴──────────────────────┐
  • ▼ ▼
  • ┌──────────────────────────────┐ ┌──────────────────────────────┐
  • │ Pro-Inflammatory Cytokines │ │ Complement Activation │
  • ├──────────────────────────────┤ ├──────────────────────────────┤
  • │ • TNF-α: Myocardial depress │ │ • C3a & C5a: Anaphylatoxins │
  • │ • IL-1β: Fever, acute phase │ │ • Membrane Attack Complex │
  • │ • IL-6: Master metabolic hub │ │ (C5b-9): Endothelial lysis │
  • │ • IL-8: Neutrophil chemotaxis│ │ • Neutrophil degranulation │
  • └──────────────────────────────┘ └──────────────────────────────┘

Key Cytokines in the Burn Inflammatory Cascade:

Tumor Necrosis Factor-alpha (TNF-α) : Released rapidly (within 1–2 hours) by wound macrophages and Kupffer cells. Induces endothelial activation, alters lipid metabolism, triggers catabolism, and functions as a direct myocardial depressant factor (MDF) .

Interleukin-1 beta (IL-1β) : Synergizes with TNF-α to stimulate hypothalamic fever pathways, activate vascular adhesion molecules (E-selectin, ICAM-1), and drive hepatic synthesis of acute-phase reactants.

Interleukin-6 (IL-6) : The central master regulator of the post-burn acute-phase response. Circulating IL-6 levels correlate directly with % TBSA, degree of hypermetabolism, and mortality risk. It orchestrates massive hepatic production of C-reactive protein (CRP), fibrinogen, and serum amyloid A while suppressing constitutive proteins (albumin, prealbumin, transferrin).

Interleukin-8 (IL-8 / CXCL8) : Potent chemokine that recruits, primes, and activates circulating neutrophils, directing them to migrate into microvascular beds of distant, uninjured organs.

Interleukin-10 (IL-10) : The primary counter-regulatory anti-inflammatory cytokine. When excessively elevated, it induces the Compensatory Anti-Inflammatory Response Syndrome (CARS) , resulting in severe post-burn immune paralysis and susceptibility to opportunistic sepsis.

2. Complement Cascade Activation & Neutrophil-Mediated Tissue Destruction

Thermal trauma activates all three complement pathways (classical, alternative, and lectin):

C3a and C5a (Anaphylatoxins) : Stimulate massive mast cell degranulation, coronary and mesenteric vasoconstriction, smooth muscle contraction, and marked increases in microvascular permeability.

Neutrophil Priming & Extravasation : High C5a and IL-8 levels upregulate CD11b/CD18 integrins on neutrophils and ICAM-1 on endothelial cells. Neutrophils undergo tethering, rolling, firm arrest, and transmigration (diapedesis) into non-burned parenchymal tissues.

Degranulation & NETosis : Trapped neutrophils release toxic proteolytic enzymes ( elastase, collagenase, myeloperoxidase ) and reactive oxygen species (ROS via NADPH oxidase), inducing bystander tissue necrosis and secondary organ damage.

3. Endothelial Glycocalyx Shedding and Systemic Capillary Leak

The endothelial glycocalyx is a delicate, 0.5–1.0 µm thick protective meshwork of membrane-bound proteoglycans (syndecan-1, glypican), glycosaminoglycans (heparan sulfate, chondroitin sulfate), and plasma proteins lining the luminal vascular surface. HEALTHY ENDOTHELIUM: BURN INJURY / SIRS STATE:

  • Luminal Blood Flow Luminal Blood Flow
  • ~~~~~~~~~~~~~~~~~~~~~~~~ (Intact Glycocalyx) ░░░░░ ░░░░ ░░░░░░░ (Glycocalyx Stripped / Shed)
  • ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬ (Endothelial Cells) ═════════════ ═════ (Adhesion Molecules Exposed)
  • Anti-thrombotic & anti-adhesive • Leukocyte rolling & firm adhesion
  • Tight permeability barrier • Microvascular thrombosis
  • Regulates shear stress & nitric oxide • Unchecked fluid/protein extravasation

In major burns, circulating metalloproteinases , heparanases , and TNF-α rapidly cleave and shed the glycocalyx. Circulating levels of syndecan-1 and heparan sulfate surge. The denuded endothelium becomes highly thrombogenic, exposes adhesion molecules, loses its selective permeability barrier, and permits generalized systemic edema in unburned muscles, lungs, and viscera.

4. Differentiating SIRS vs. Burn Hypermetabolic Baseline

One of the most critical diagnostic challenges in burn critical care is distinguishing the expected baseline hypermetabolic/inflammatory state of a major burn from true secondary infection or sepsis .

Clinical Parameter Traditional ACCP/SCCM SIRS Criteria Expected Baseline in Major Burn (≥20% TBSA) ABA Sepsis Consensus Trigger Threshold

  • Temperature >38.0°C or <36.0°C 38.0°C – 38.8°C (Hypothalamic reset) >39.0°C or <36.5°C
  • Heart Rate >90 bpm 100 – 120 bpm (High catecholamines) >130 bpm (or sustained unexplained increase)

Respiratory Rate >20 breaths/min or PaCO2 <32 22 – 28 breaths/min (Hypermetabolism) >30 breaths/min (or MV >12 L/min)

WBC Count >12,000 or <4,000 /µL 12,000 – 18,000 /µL (Demargination) >20,000 or <4,000 /µL (or >10% bands)

Platelet Count Not specified in SIRS Thrombocytosis (rebound after day 3) Thrombocytopenia (<100,000 /µL or >50% drop)

Serum Glucose >140 mg/dL (in non-diabetic) 140 – 180 mg/dL (Insulin resistance) >200 mg/dL (Refractory to insulin infusion)

Enteral Nutrition Not specified Tolerating target rate Enteral feeding intolerance (residuals >2x rate)

Note

Clinical Diagnostic Reality: Nearly 100% of patients with burns ≥20% TBSA fulfill standard SIRS criteria for weeks post-injury without harboring an active infection. The Certified Burn Registered Nurse must recognize that traditional SIRS parameters cannot be used in isolation to diagnose sepsis in burn patients.

5. Pathophysiology of Multiple Organ Dysfunction Syndrome (MODS)

MODS represents the progressive, sequential dysfunction of two or more organ systems resulting from uncontrolled systemic inflammation, microvascular thrombosis, and sustained tissue hypoperfusion. ┌────────────────────────────────────────┐

  • │ Systemic Inflammatory Response (SIRS) │
  • │ + Microvascular Capillary Leak │
  • └───────────────────┬────────────────────┘
  • │
  • ┌──────────────────────┬───────────────┴───────────────┬──────────────────────┐
  • ▼ ▼ ▼ ▼
  • ┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐
  • │ 1. Pulmonary │ │ 2. Renal │ │ 3. Hepatic │ │ 4. Gastro- │
  • │ (ALI / ARDS) │ │ (ATN / AKI) │ │ (Steatosis) │ │ intestinal │
  • ├─────────────────┤ ├─────────────────┤ ├─────────────────┤ ├─────────────────┤
  • │ • Neutrophil │ │ • Ischemia- │ │ • Massive │ │ • Splanchnic │
  • │ sequestration │ │ reperfusion │ │ lipolysis & │ │ vasoconstric- │
  • │ • Alveolar │ │ • Myoglobin/ │ │ free fatty │ │ tion │
  • │ flooding │ │ hemoglobin │ │ acid flux │ │ • Mucosal │
  • │ • Surfactant │ │ pigment casts │ │ • Impaired │ │ breakdown │
  • │ inactivation │ │ • Endothelin-1 │ │ synthesis │ │ • Bacterial │
  • │ • Refractory │ │ mediated │ │ • Intrahepatic │ │ translocation │
  • │ hypoxemia │ │ vasospasm │ │ cholestasis │ │ • Curling ulcer │
  • └─────────────────┘ └─────────────────┘ └─────────────────┘ └─────────────────┘
  • 1. Pulmonary Dysfunction (ALI / ARDS)

Mechanism : Inflammatory mediators (TNF-α, IL-1β, C5a) cause extensive neutrophil sequestration in pulmonary capillaries. Activated neutrophils release elastase and free radicals, injuring alveolar type I and type II pneumocytes and endothelial cells.

Consequence : Proteinaceous exudate floods alveoli, inactivates pulmonary surfactant, and causes microatelectasis. This leads to severe intrapulmonary shunting, marked reduction in static lung compliance, and refractory hypoxemia ( P a O 2 / F i O 2 ≤ 300 PaO_2/FiO_2 \le 300 P a O 2 ​ / F i O 2 ​ ≤ 300 for ALI; ≤ 200 \le 200 ≤ 200 for moderate ARDS; ≤ 100 \le 100 ≤ 100 for severe ARDS).

2. Renal Dysfunction (Acute Kidney Injury / ATN)

Early Phase (<48 hours) : Severe prerenal hypoperfusion from hypovolemia, compounded by renal vasoconstriction driven by angiotensin II, norepinephrine, and endothelin-1. If uncorrected, evolves into Acute Tubular Necrosis (ATN) .

Pigment Nephropathy : High-voltage electrical burns or deep thermal contact burns cause rhabdomyolysis and extensive hemolysis, releasing massive quantities of myoglobin (molecular weight 17.8 kDa) and hemoglobin . In the acidic, hypoperfused renal tubules, these pigments precipitate with Tamm-Horsfall protein to form obstructive tubular casts, while free iron generates cytotoxic hydroxyl radicals.

Late Phase (>48 hours) : Sepsis-induced cytokine nephrotoxicity, exposure to nephrotoxic antimicrobials (vancomycin, aminoglycosides, colistin), and intra-abdominal hypertension ( I A P ≥ 12 mmHg IAP \ge 12\text{ mmHg} I A P ≥ 12 mmHg ) impairing renal perfusion pressure.

3. Hepatic Dysfunction

Fatty Infiltration (Hepatic Steatosis) : The hypermetabolic catecholamine and cortisol surge drives uncoupled peripheral lipolysis. Massive influxes of free fatty acids overwhelm hepatic mitochondrial β-oxidation, accumulating as triglycerides in hepatocytes. Hepatomegaly can develop within days.

Impaired Synthetic Function : Shift from constitutive protein synthesis (hypoalbuminemia, low prealbumin) to acute-phase proteins; delayed clearance of lactate, bilirubin, and medications.

Intrahepatic Cholestasis & Acalculous Cholecystitis : Sludging of bile, microvascular ischemia of the gallbladder wall, and total parenteral nutrition (TPN) predispose to acute acalculous cholecystitis.

4. Gastrointestinal Dysfunction & Bacterial Translocation

Splanchnic Hypoperfusion : Endogenous catecholamines and vasopressin selectively constrict mesenteric arterioles to divert blood flow to the brain and heart.

Epithelial Barrier Destruction : Mucosal ischemia depletes ATP in enterocytes, causing detachment of mucosal villi and breakdown of claudin and occludin tight junctions .

Bacterial & Endotoxin Translocation : Enteric bacteria (e.g., Pseudomonas aeruginosa , Escherichia coli , Enterococcus ) and lipopolysaccharide (LPS / endotoxin) traverse the denuded mucosal barrier into the mesenteric lymphatics and portal circulation, directly fueling second-wave SIRS and distant organ failure.

Curling's Ulcers : Severe acute peptic erosion of the stomach or duodenum resulting from mucosal ischemia and reduced protective prostaglandin/bicarbonate secretion.

6. Clinical Monitoring and MODS Prevention Strategies

Early Resuscitation Optimization : Rapidly restore systemic microvascular perfusion to abort prerenal ischemia and gut hypoperfusion without causing "fluid creep".

Early Enteral Nutrition (within 6–12 hours) : Continuous trophic enteral feeding maintains splanchnic blood flow, stimulates mucosal secretomotor activity, preserves epithelial tight junctions, and prevents bacterial translocation.

Serial Organ Failure Assessment (SOFA Scoring) : Daily calculation of SOFA scores to identify subclinical organ failure across respiratory ( P a O 2 / F i O 2 PaO_2/FiO_2 P a O 2 ​ / F i O 2 ​ ), hematologic (platelets), hepatic (bilirubin), cardiovascular (MAP/vasopressor requirement), neurologic (GCS), and renal (creatinine/urine output) domains.

Early Burn Wound Excision : Surgical removal of necrotic burn eschar within 24 to 72 hours permanently eliminates the primary source of DAMPs and inflammatory cytokines.